{"id":"NCT03162458","sponsor":"Materia Medica Holding","briefTitle":"Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections","officialTitle":"Multicenter Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01-22","primaryCompletion":"2015-04-29","completion":"2015-04-29","firstPosted":"2017-05-22","resultsPosted":"2018-08-03","lastUpdate":"2018-11-28"},"enrollment":142,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Upper Respiratory Infections"],"interventions":[{"type":"DRUG","name":"Anaferon for children (liquid dosage form)","otherNames":[]},{"type":"DRUG","name":"Placebo (liquid dosage form)","otherNames":[]}],"arms":[{"label":"Anaferon for children","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Purpose of the study:\n\n* To assess efficacy of Anaferon for children liquid dosage form in the treatment of acute upper respiratory tract infections.\n* To assess safety of Anaferon for children liquid dosage form in the treatment of acute upper respiratory tract infections.","primaryOutcome":{"measure":"Average Illness Duration (the Interval Between the Start of the Trial Treatment and the Time When Recovery/Improvement - Based on Patient Diary Data)","timeFrame":"From the time of randomization until the time of recovery/improvement, assessed up to 14 days","effectByArm":[{"arm":"Anaferon for Children","deltaMin":87.7,"sd":31.5},{"arm":"Placebo","deltaMin":103.3,"sd":19.4}],"pValues":[{"comp":"OG000 vs OG001","p":"0.007"}]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":71},"commonTop":["Rash","Rhinitis purulent","Hyperactivity","Herpes Labialis","Diarrhea"]}}